Maxwell Biomedical
Pre-clinicalMaxwell Rhythm360 is a breakthrough, advanced therapy for atrial fibrillation. It employs non-destructive Sinus Rhythm Therapy (SRT) to restore functional sinus rhythm and optimize atrial function in AF-HFpEF patients. Advanced inter-cardiac monitoring detects AF triggers, enabling the SRT to preemp
Founded
2019
Focus
Medical DevicesCardiovascular
About
Maxwell Rhythm360 is a breakthrough, advanced therapy for atrial fibrillation. It employs non-destructive Sinus Rhythm Therapy (SRT) to restore functional sinus rhythm and optimize atrial function in AF-HFpEF patients. Advanced inter-cardiac monitoring detects AF triggers, enabling the SRT to preemp
Company Info
TypePrivate
Founded2019
LocationSan Francisco, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile